IRulya Therapeutics QNCX
NASDAQ QNCX
$34.45 +2.42 (+7.56%)
At close: Oct 19, 2026 · 4:00 PM EDT

Quince Therapeutics, Inc. (QNCX) Enterprise Value (2019 - 2026)

Updated

Quince Therapeutics (QNCX) recorded Enterprise Value of $139.37 million in Q2 2026, up 159.2% from $53.77 million a year earlier.

Analysis

Quince Therapeutics, Inc. (QNCX) Enterprise Value (2019 - 2026) Analysis & Trends

For FY2025, Quince Therapeutics reported Enterprise Value of $168.93 million, up 307.1% from FY2024.

  • Annual Enterprise Value has a five-year compound annual growth rate of -24.5% (FY2020 to FY2025).
  • Across earlier years, Enterprise Value came in at $41.5 million in FY2024, -$29.94 million in FY2023, -$67.16 million in FY2022 and $272.74 million in FY2021 (-60.3%).
  • Quarterly Enterprise Value has ranged from -$67.16 million in Q4 2022 to $2.62 billion in Q3 2021 over the past five years.
  • Per Business Quant, the preceding three quarters came in at -$8.99 million (Q1 2026), $168.93 million (Q4 2025) and $62.54 million (Q3 2025).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 139.37 Mn
Mar 31, 2026 -8.99 Mn
Dec 31, 2025 168.93 Mn
Sep 30, 2025 62.54 Mn
Jun 30, 2025 53.77 Mn
Mar 31, 2025 27.04 Mn
Dec 31, 2024 41.50 Mn
Sep 30, 2024 -14.26 Mn
Jun 30, 2024 -26.99 Mn
Mar 31, 2024 -22.01 Mn
Dec 31, 2023 -29.94 Mn
Sep 30, 2023 -42.52 Mn
Jun 30, 2023 -32.89 Mn
Mar 31, 2023 -33.61 Mn
Dec 31, 2022 -67.16 Mn
Sep 30, 2022 -46.29 Mn
Jun 30, 2022 -14.79 Mn
Mar 31, 2022 95.10 Mn
Dec 31, 2021 272.74 Mn
Sep 30, 2021 2.62 Bn
API Access

Quince Therapeutics, Inc. Enterprise Value API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=enterprise-value&ticker=QNCX&period=max&api_key=YOUR_API_KEY